Categories
- ALS Treatment
- Ataxia Treatment
- Autism Treatment
- Batten Disease Treatment
- Brain Injury Treatment
- Cerebral Palsy Treatment
- Epilepsy Treatment
- Femtomedicine
- genetic-medicine
- Hormone Replacement Therapy
- MS Treatment
- Muscular Dystrophy Treatment
- Nanomedicine
- Parkinson's Treatment
- Picomedicine
- Spinal Cord Injury Treatment
- Stem Cell Research
- Stem Cell Therapy
- Stroke Treatment
- Uncategorized
Archives
Recommended Sites
- Affordable Web Hosting
- Bed Bug Registry
- Bing Search
- Broken Link Checker
- Browser Shots
- Cancer Specialist
- Conscious Evolution
- Cryomedical Blog
- Free Health Insurance Quote
- Free Loan Quote
- Genistein Net
- Google Search
- HGH
- HGH Injections
- HGH Prescription
- HGH Side Effects
- HGH Therapy
- Hormone Therapy
- Human Growth Hormone
- Injectable Testosterone
- Medical School Review
- Miami Spray Tanning
- New York City Real Estate
- Palm Beach Real Estate
- POLIMEDICAL CENTRO POLISPECIALISTICO
- Ron Paul 2012
- Ron Paul TV
- SEO Web Design
- Start Your Own Internet Services Company
- Testosterone
- Testosterone Therapy
- Topamax Lawsuit
- Weight Loss
- WholeSale Domain Names
- Yahoo Search
-
Tag Archives: and-development
Animal Cell Therapies Announces Cell Inventory Value at $6 Million
SAN DIEGO–(BUSINESS WIRE)– Animal Cell Therapies (ACT), a company specializing in veterinary diagnostics and cell-based therapies, today announced that its stem cell inventory is valued at more than $6 million. The evaluation, conducted by Cheetahlink and Capital Consulting Services, demonstrates the importance of this first step in the company’s mission to improve and extend the lives of dogs through innovative stem cell products and services. When Animal Cell Therapies was created, the company partnered with a select group of researchers, scientists and collaborators from the U.S. Continue reading
Posted in Stem Cell Research
Tagged and-development, animal, customers, importance, lives, manifestation, san, stable-finished, therapies, valuation
Comments Off
Smart injectable nanotherapeutics could improve treatment for Type I diabetes
A research collaboration between the Wyss Institute for Biologically Inspired Engineering at Harvard University and Children's Hospital Boston has developed “smart” injectable nanotherapeutics that can be programmed to selectively deliver drugs to the cells of the pancreas. Although this nanotechnology will need significant additional testing and development before being ready for clinical use … Continue reading
Posted in Batten Disease Treatment
Tagged and-development, before-being, biologically, cells, clinical-use-, engineering, harvard, hospital, hospital-boston, nanotechnology, pancreas, the-cells, the-pancreas, will-need, wyss
Comments Off
ASSERT Sheds Light on the Role of Subclinical AF in Stroke
A new study??published in the??New England Journal of Medicine sheds some much-needed light on the??precise role of subclinical atrial fibrillation (AF) in the prognosis and development of ischemic stroke.??ASSERT (Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients and the Atrial Fibrillation Reduction Atrial Pacing Trial) followed 2580 patients with a newly implanted … Continue reading
Posted in Stroke Treatment
Tagged a-newly-implanted, and-development, atrial-fibrillation-, england-journal, followed-2580, light-on-the, medicine, new-study, newly-implanted, pacemaker, pacing, pacing-trial, reduction, sheds-some
Comments Off
Intellect Neurosciences Files Appeal in Europe in Response to Opposition Proceedings Instituted by Elan …
NEW YORK , Dec. 15, 2011 /PRNewswire/ — Intellect Neurosciences, Inc. (OTCBB: ILNS.PK – News), a biopharmaceutical company engaged in the discovery and development of disease-modifying therapeutic agents for the … Continue reading
Posted in Ataxia Treatment
Tagged agents-for, and-development, discovery, ilns, intellect-neurosciences, new, otcbb, the-, the-discovery-
Comments Off
Cure Duchenne Appoints Michael Kelly as Chief Scientific Officer
NEWPORT BEACH, Calif.–(BUSINESS WIRE)–CureDuchenne, a national nonprofit that funds research to find a cure for Duchenne muscular dystrophy, today announced the appointment of Dr. Michael G. Kelly as Chief Scientific Officer, a key scientific position within the Duchenne community. Continue reading
Posted in Muscular Dystrophy Treatment
Tagged a-cure-for, a-key-scientific, a-national-nonprofit, a-senior-pharmaceutic, and-development, calif-, chief, the-appointment, within-the-duchenne
Comments Off
STEDESA™ Clinical Data Presented at 2011 American Epilepsy Society Annual Meeting
MARLBOROUGH, Mass.–(BUSINESS WIRE)–STEDESA clinical data presented at 2011 AES Meeting. Continue reading
Posted in Epilepsy Treatment
Tagged aes, and-development, clinical-data, during-the, during-the-third, mass-, meeting, meeting-sunovion, path-targets, presented-at-2011, reaffirms-commitment, third, third-quarter, wire-
Comments Off
Neeses native receives award for work in genetics
A Neeses native who is co-founder and former director of the Greenwood Genetic Center has received a professional service award for his work in the support of individuals with intellectual and development disabilities. Continue reading
Posted in genetic-medicine
Tagged and-development, center, co-founder-and, for-his, greenwood, has-received, service-award-, support, with-intellectual, work
Comments Off
Intellect Neurosciences Responds to Official Action by United States Patent and Trademark Office in Relation to its …
NEW YORK, Nov. 3, 2011 /PRNewswire/ — Intellect Neurosciences, Inc. Continue reading
Posted in Ataxia Treatment
Tagged agents-for, and-development, discovery, diseases-announced, intellect, intellect-neurosciences, otcbb, the-discovery-, the-treatment, treatment
Comments Off